EDX/20/1154
Date of prep: December 2020
Prescribing information and
adverse events reporting
For healthcare professionals only
EDX/20/1154
Date of prep: December 2020
Prescribing information and
adverse events reporting
For healthcare professionals only
We are incredibly proud to welcome friend and colleague of PIP Professor Lis Neubeck to deliver this interactive session. Lis is Professor and Head of Cardiovascular Health in the School of Health and Social Care at Edinburgh Napier University.
This live event will cover hot topics in cardiology and will provide an update on the most recent developments. There will be a particular focus on innovative approaches to the management of AF.
This webinar has been sponsored by Daiichi Sankyo Ltd. They have had no input into any aspect of the design and/or delivery of the advertised webinar; however please note that Daiichi Sankyo Ltd will make a short independent promotional presentation during the event. This event is for registered healthcare professionals only.
During this webinar you will:
Date |
26th January 2021 |
Time |
19.30-21.00 |
To register for the live online event simply click the link below. If you would like to be kept up to date about future events you can sign up for our newsletters below.
More about Lis Neubeck
In addition to the roles above, Lis is an Honorary Professor of Sydney Nursing School, Charles Perkins Centre, University of Sydney. Lis’s research focuses on innovative solutions to secondary prevention of cardiovascular disease, identification and management of atrial fibrillation, and use of new technologies to improve access to health care. She is an Adjunct Professor, School of Nursing and Midwifery, Faculty of Medicine, Nursing, and Health Sciences at Flinders University in Adelaide. Lis completed a National Health and Medical Research Council of Australia Early Career Fellowship and is an Honorary Senior Research Fellow at the George Institute for Global Health.
Her research focuses on innovative solutions to secondary prevention of cardiovascular disease, identification and management of atrial fibrillation, and use of new technologies to improve access to health care. Lis has secured over £1.5m in competitive research funding and has won notable prizes and awards for her research, including the prestigious Cardiac Society of Australia and New Zealand Nursing Prize (2013). She has supervised to completion 4 Honours students; all achieved Upper-Class Honours; and 4 PhD students; and she has 4 current PhD students, 1 MRes student.
Lis is Past President of the Australian Cardiovascular Health and Rehabilitation Association (President 2015-2017), served on the board of the Cardiovascular Nursing Council of the Cardiac Society of Australia and New Zealand (2013-2016), and was the Australian representative on the Global Alliance for Prevention of Cardiovascular Disease of the World Heart Federation. She served on the Faculty of the eCardiology and eHealth Conference in Berlin (October 2016). She is the President-Elect of the Association of Cardiovascular Nurses and Allied Professionals of the European Society of Cardiology and serves on the programme committee of the EuroHeartCare conference. She is also a Fellow of the European Society of Cardiology.
If you would like to be kept informed about future live events being run by Pharmacy in Practice simply fill in the form below to give us permission to contact you appropriately.
Feedback from previous live events
“This was an excellent session, I learnt a lot, and have a lot of follow up reading to do, I wasn’t familiar with the GINA report and some of the other resources and websites mentioned are new to me too.”
“It’s brilliant that you have organised this session, it’s definitely an area where pharmacists can do so much more to improve care and help prevent deaths. You mooted perhaps a further session – I think this would be very worthwhile to reinforce learning.”
Click here to view our CPD disclaimer.
Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.
This site is for healthcare professionals, please confirm you are a healthcare professional to continue.
Begin the discussion right here